Anesthesiology Doctors in Akron, OH Accepting Medicare

70 Anesthesiology doctors found. Showing 61 - 70

Kevin Mcdonnell, MD Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 224 W Exchange St, Suite 220, Akron, OH 44302 Phone: 330-344-7040    Fax: 330-344-1714

Dr. Bradley Jarold Riemenschneider, MD Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-8823    Fax: 330-296-6535

Dr. Brandon Anthony Roberts, MD Anesthesiology - Pediatric Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-1000

Andrew Paul Blaut, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-6000

Joseph Kirk, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-6000

Kenneth Daniel Snider, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-6000

Dr. Daniel Jay Goldstein, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Perkins Sq, Akron, OH 44308 Phone: 330-543-1000

Stephen Hirschfeld, M.D. Anesthesiology Medicare: Not Enrolled in Medicare Practice Location: 400 Wabash Ave, Akron, OH 44307 Phone: 330-344-6000

Dr. Michael Robert Kaufmann, M.D. Anesthesiology Medicare: Accepting Medicare Assignments Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 330-344-7040    Fax: 330-344-1714

Duncan Polot, Anesthesiology Medicare: Medicare Enrolled Practice Location: 1 Akron General Ave, Akron, OH 44307 Phone: 734-255-6241

News Archive

Hope for ovarian cancer patients not responding to conventional chemotherapy

Investigators at the Translational Genomics Research Institute (TGen) have discovered a way that may help ovarian cancer patients who no longer respond to conventional chemotherapy.

Therapeutic candidate BLU-554 has significant anti-tumor activity in HCC models

Blueprint Medicines today announced new preclinical data demonstrating that BLU-554, a selective and potent inhibitor of fibroblast growth factor receptor 4 (FGFR4), has significant anti-tumor activity in models of hepatocellular carcinoma (HCC) that are dependent on FGFR4 signaling.

Press Ganey Associates collaborates with HMA to improve patient care

Press Ganey Associates, Inc. today announced a broad partnership with Health Management Associates, Inc. to help measure and improve satisfaction and engagement among patients, employees, and physicians. The company started working with HMA on October 1, 2009.

AqueSys secures $35 million in Series C financing round

AqueSys, Inc., a medical device company that develops, manufactures and distributes proprietary implants for glaucoma, today announced that it has secured $35 million in Series C financing. The round was led by Longitude Capital and Rho Ventures, with participation from existing investors Accuitive Medical Ventures, The Carlyle Group and SV Life Sciences.

Study indicates that dispatch accuracy to older trauma patients could be improved

In a retrospective study of trauma patients over 65 years of age attended by KSS, it was found that, although a number of these patients had sustained a minor injury through seemingly innocuous mechanisms, a high proportion of this group required advanced clinical interventions and subsequent tertiary level care at a major trauma center.

Read more Medical News

› Verified 4 days ago

• 1
• 2
• 3
• 4(current)